"According to the Spectrem Group, which recently polled the country's wealthiest people, they're the most optimistic they've been in months," says Marc Lichtenfeld.

The contributing editor to Investment U explains, "Let's take a look at 3 stocks that millionaires (and aspiring ones) should pay attention to: Apple (AAPL), Bristol-Myers Squibb (BMY) and Varian Medical Systems (VAR).

"And according to Fidelity, 83% of millionaires surveyed said the financial crisis did not shake their confidence in investing. And of those who said they'll invest more money in the stock market, nearly 60% of them plan to buy technology stocks. And just under half expect to acquire pharmaceutical and healthcare stocks.

"I love going to health care conferences, where companies often reveal new technologies, groundbreaking drugs, or novel ways of attacking diseases," says Marc Lichtenfeld.

The contributing editor to Investment U explains, "Here's a review of four interesting presentations I recently saw at LifeTech Capital's small-cap health care conference in Miami: Inovio Pharmaceuticals (INO), Nabi Pharmaceuticals (NABI), NeoStem (NBS), and Oculus Innovative Sciences (OCLS).

"There are also people who avoid the doctor's office, not because they're afraid of needles, but because they can't afford it," says growth stock specialist Marc Lichtenfeld.

The contributing editor to Investment U explains, "However, times are changing. The new health care bill will enable millions more people to get their various conditions checked out. As a result, the diagnostics industry should boom.

"With state governments going bankrupt, the last thing bureaucrats want to do is spend precious resources on managing their prison systems," explains growth stock expert Marc Lichtenfeld.

The senior analyst for Xcelerated Profits Report suggests, "For-profit institutions are usually able to provide prison services more efficiently than the government can. And there's one company that stands out -- The GEO Group (NYSE: GEO)."

"Nearly two-and-a-half million people are behind bars in American prisons. The U.S. incarceration rate is five times higher than the world average and the U.S. prison population is still rising.

"It's no secret that the world is facing a severe water shortage; many experts, believe the next major war will be fought over water, not oil," says Marc Lichtenfeld.

The senior equity analyst for the top-notch growth stock advisory, Xcelerated Profits Report explains, "Desalination is likely the only way the world's water needs will be met. And one company that will benefit is Energy Recovery (NASDAQ: ERII).

"Just how severe is the shortage? Demand for fresh water will exceed supply by 50% in 2025, with one-third of the Earth's population living in countries with water scarcity. The bottom line is that if we plan to feed and provide water for everyone, we're going to have to find a way to use more water more efficiently.

"Carl Icahn - one of Wall Street's most renowned and successful investors - is on another mission; this pitbull is sinking his teeth into one of the companies in our portfolio - Enzon Pharmaceuticals (NASDAQ: ENZN)," notes Marc Lichtenfeld.

In Xcelerated Profits Report, the senior analyst and noted healthcare sector expert takes a look at the small cap biotechnology, which is involved in developing products for the treatment of cancer.

"With an infamous reputation for diving into stocks that he perceives as undervalued and shaking up management teams in order to boost shareholder value, Icahn us one of the best 'business partners' we could have.

"One of the big reasons why we recommended Enzon was because some major institutional investors are clamoring for change at the company. They contend that if Enzon was better at maximizing its true potential, the stock could easily vault from its current undervalued state and generate some real wealth for its shareholders.